Allergic and pseudoallergic reactions to antalgics, antipyretics and non-steroidal anti-inflammatory drugs;Les réactions allergiques et pseudoallergiques aux antalgiques, antipyrétiques et anti-inflammatoires non stéroïdiens

Revue Francaise d'Allergologie et d'Immunologie Clinique

Volumn 46, Issue 6, 2006, Pages 576-583

  Ponvert, C ^a   Scheinmann, P ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Antalgics; Antipyretics; Child; Drug hypersensitivity; Non steroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIPYRETIC AGENT; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ALLERGIC REACTION; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; ASTHMA; CROSS REACTION; DRUG HYPERSENSITIVITY; HUMAN; RHINITIS; RISK FACTOR; SKIN MANIFESTATION; URTICARIA;

EID: 33750738130     PISSN: 03357457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.allerg.2006.07.003     Document Type: Article

References (132)

1. Arndt K.A., and Jick H. Rates of cutaneous reactions to drugs: a report from the Collaborative Drug Surveillance Program. J. Am. Med. Assn. 235 (1976) 918-923
2. Borda I.T., Slone D., and Jick H. Assessment of adverse reactions within a drug surveillance program. J. Am. Med. Assn. 205 (1968) 645-647
3. Haddi E., Charpin M., Tafforeau M., Kulling G., Lanteaume A., Kleisbauer J.P., et al. Atopy and systemic reactions to drugs. Allergy 45 (1990) 236-239
4. Hurwitz N. Admissions to hospital due to drugs. BMJ 1 (1969) 539-540
5. Rebelo Gomes E., and Demoly P. Epidemiology of hypersensitivity drug reactions. Curr. Opin. Allergy Clin. Immunol. 5 (2005) 309-316
6. Beltrani V.S. Cutaneous manifestations of adverse drug reactions. Immunol. Allergy Clin. N. Amer. 18 (1998) 867-895
7. Hung O.R., Bands C., Laney G., Drover D., Stevens S., and MacSween M. Drug allergies in a surgical population. Can. J. Anaesth. 41 (1994) 1149-1155
8. Gurwitz J.H., and Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann. Intern. Med. 114 (1991) 956-966
9. Ibia E.O., Schwartz R.H., and Wiedermann B.L. Antibiotic rashes in children: a survey in a private practice setting. Arch. Dermatol. 136 (2000) 849-854
10. Anderson J.A. Allergic reactions to drugs and biological agents. J. Am. Med. Assn. 268 (1992) 2845-2857
11. Hunziker T., Kunzi E.P., Braunschweig S., Zehnder D., and Hoigné R. Comprehensive drug monitoring (CHDM): adverse skin reactions, a 20-year survey. Allergy 52 (1997) 388-393
12. Botey J., Ibero M., Malet A., Marin A., and Eseverri J.L. Aspirin-induced recurrent urticaria and recurrent angioedema in non atopic children. Ann. Allergy 53 (1984) 265-267
13. Sanchez-Borges M., Capriles-Hulett A., and Caballero-Fonseca F. NSAID-induced urticaria and angioedema: a reappraisal of its clinical management. Am. J. Clin. Dermatol. 3 (2002) 599-607
14. Settipane G.A. Aspirin and allergic diseases: a review. Am. J. Med. 74 (1983) 102-109
15. Bochenek G., Nizankowska E., and Szczeklik A. Testing for aspirin hypersensitivity. Allergy 57 (2002) 562-565
16. Falliers C.J. Aspirin and subtypes of asthma: risk factor analysis. J. Allergy Clin. Immunol. 52 (1973) 141-147
17. Jenkins C., Castello J., and Hodge L. Systematic review of aspirin-induced asthma and its implications for clinical practice. BMJ 328 (2004) 434-440
18. Rachelefsky G.S., Coulson A., Siegel S.C., and Stiehm E.R. Aspirin intolerance in chronic childhood asthma detected by oral challenge. Pediatrics 56 (1975) 443-448
19. Settipane G.A., Chafee F.H., and Klein D.E. Aspirin intolerance II. Prospective study in an atopic and normal population. J. Allergy Clin. Immunol. 53 (1974) 200-204
20. Spector S.L., Wangaard C.H., and Farr R.S. Aspirin and concomitant idiosyncrasies in adult asthmatic patients. J. Allergy Clin. Immunol. 64 (1979) 500-506
21. Vally H., Taylor M.L., and Thompson P.J. The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients. Thorax 57 (2002) 569-574
22. Bochenek G., Nizankowska E., and Szczeklik A. The atopic trait in hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy 51 (1996) 16-23
23. Kalyoncu A.F., Karakaya G., Sahin A.A., and Baris Y.I. Occurence of allergic conditions in asthmatics with analgesic intolerance. Allergy 54 (1999) 428-435
24. Pastorello E.A., Zara C., Riario-Sforza G.G., Pravettoni V., and Incorvaia C. Atopy and intolerance of antimicrobial drugs increase the risk of reactions to acetaminophen and nimesulide in patients allergic to nonsteroidal anti-inflammatory drugs. Allergy 53 (1998) 880-884
25. Sanchez-Borges M., and Capriles-Hulett A. Atopy is a risk factor for nonsteroidal anti-inflammatory drug hypersensitivity. Ann. Allergy Asthma Immunol. 84 (2000) 101-106
26. Speer F., Denison T.R., and Baptist J.E. Aspirin allergy. Ann. Allergy 46 (1981) 123-126
27. Quiralte J., Sanchez-Garcia F., Torres M.J., Blanco C., Castillo R., Ortega N., et al. Association of HLA-DR11 with the anaphylactoid reaction caused by nonsteroidal anti-inflammatory drugs. J. Allergy Clin. Immunol. 103 (1999) 685-689
28. Kowalski M.L., Woszczek G., Bienkiewicz B., and Mis M. Association of pyrazolone drug hypersensitivity with HLA-DQ and DR antigens. Clin. Exp. Allergy 28 (1998) 1153-1158
29. Lympany P.A., Welsh K.I., Christie P.E., Schmitz-Schumann M., Kemeny D.M., and Lee T.H. An analysis with sequence-specific ologonucleotide probes of the association between aspirin-induced asthma and antigens of the HLA system. J. Allergy Clin. Immunol. 92 (1993) 114-123
30. Mullarkey M.F., Thomas P.S., Hansen J.A., Webb D.R., and Nisperos B. Association of aspirin-sensitive asthma with HLA-DQw2. Am. Rev. Respir. Dis. 133 (1986) 261-263
31. Lesko S.M., and Mitchell A.A. The safety of acetaminophen and ibuprofen among children younger than two years old. Pediatrics 104 (1999) e39-e44
32. Martin-Munoz F., Moreno-Ancillo A., Dominguez-Noche C., Diaz-Pena J.M., Garcia-Ara C., Boyano T., et al. Evaluation of drug-related hypersensitivity reactions in children. Invest Allergol. Clin. Immunol. 9 (1999) 172-177
33. Titchen T., Cranswick N., and Beggs S. Adverse drug reactions to nonsteroidal anti-inflammatory drugs, COX-2 inhibitors and paracetamol in a paediatric hospital. Br. J. Clin. Pharmacol. 59 (2005) 718-723
34. Sanchez-Borges M., Capriles-Behrens E., and Caballero-Fonseca F. Hypersensitivity to nonsteroidal anti-inflammatory drugs in childhood. Pediatr. Allergy Immunol. 15 (2004) 376-380
35. Asero R. Oral aspirin challenges in patients with a history of intolerance to single nonsteroidal anti-inflammatory drugs. Clin. Exp. Allergy 35 (2005) 713-716
36. Hassani A., Ponvert C., Karila C., Le Bourgeois M., de Blic J., and Scheinmann P. Hypersensibilité aux anti-inflammatoires non stéroïdiens chez l'enfant : résultats d'une étude de 164 cas. Rev. Fr. Allergol. Immunol. Clin. 46 (2006) 369 (Abst)
37. Kvedariene V., Bencherioua A.M., Messaad D., Godard P., Bousquet J., and Demoly P. The accuracy of the diagnosis of suspected paracetamol (acetaminophen) hypersensitivity: results of a single-blinded trial. Clin. Exp. Allergy 32 (2002) 1366-1369
38. Schubert B., Grosse Perdekamp M.T., Pfeuffer P., Raith P., Bröcker E.B., and Trautmann A. Nonsteroidal anti-inflammatory drug hypersensitivity: fable or reality?. Eur. J. Dermatol. 15 (2005) 164-167
39. Stevenson D.D., Sanchez-Borges M., and Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann. Allergy Asthma Immunol. 87 (2001) 177-180
40. Szczeklik A., and Stevenson D.D. Aspirin-induced asthma : advances in pathogenesis, diagnosis and management. J. Allergy Clin. Immunol. 111 (2003) 913-921
41. Asero R. Multiple sensitivity to NSAIDs. Allergy 55 (2000) 893-894
42. Asero R. Tolerability of rofexocib. Allergy 56 (2001) 916-917
43. Carmona M.J., Blanca M., Garcia A., Fernandez S., Burgos F., Miranda A., et al. Intolerance to piroxicam in patients with adverse reactions to nonsteroidal anti-inflammatory drugs. J. Allergy Clin. Immunol. 90 (1992) 873-879
44. Debley J.S., Carter E.R., Gibson R.L., Rosenfeld M., and Redding G.J. The prevalence of ibuprofen-sensitive asthma in children: a randomized controlled bronchoprovocation challenge study. J. Pediatr. 147 (2005) 233-238
45. Enrique E., Cistero-Bahima A., San Miguel-Moncin M.M., and Alonso R. Rofecoxib should be tried in NSAID hypersensitivity. Allergy 55 (2000) 1090
46. Kidon M.I., Kang L.W., Chin C.W., Hoon L.S., See Y., Goh A., et al. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal anti-inflammatory drugs among young, asian, atopic children. Pediatrics 16 (2005) e675-e680
47. Kosnik M., Music E., Matjaz F., and Suskovic S. Relative safety of meloxicam in NSAID-intolerant patients. Allergy 53 (2000) 1231-1233
48. Nettis E., Marcandrea M., Ferrannini A., and Tursi A. Tolerability of nimesulide and paracetamol in patients with NSAID-induced urticaria/angioedema. Immunopharmacol. Immunotoxicol. 23 (2001) 343-354
49. Settipane R.A., and Stevenson D.D. Cross-sensitivity with acetaminophen in aspirin-sensitive subjects with asthma. J. Allergy Clin. Immunol. 84 (1989) 26-33
50. Settipane R.A., Schrank P.J., Simon R.A., Mathison D.A., Christiansen S.C., and Stevenson D.D. Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects. J. Allergy Clin. Immunol. 96 (1995) 480-485
51. Valero A., Baltasar M., Enrique E., Pau L., Dordal M.T., Cistero A., et al. NSAID-sensitive patients tolerate rofecoxib. Allergy 57 (2002) 1214
52. Boussetta K., Ponvert C., Karila C., Le Bourgeois M., de Blic J., and Scheinmann P. Les réactions d'hypersensibilité au paracétamol chez l'enfant : une revue de la littérature à propos d'un cas. Rev. Fr. Allergol. Immunol. Clin. 44 (2004) 523-526
53. Boussetta K., Ponvert C., Karila C., Le Bourgeois M., de Blic J., and Scheinmann P. Hypersensitivity reactions to paracetamol in children. Allergy 60 (2005) 1174-1177
54. Arnaud A. Allergy and intolerance to nonsteroidal anti-inflammatory agents. Clin. Rev. Allergy Immunol. 13 (1995) 245-251
55. Bircher A.J. Drug-induced urticaria and angioedema caused by non IgE-mediated pathomechanisms. Eur. J. Dermatol. 9 (1999) 657-663
56. Cousin F., Philips K., Favier B., and Nicolas J.F. Drug-induced urticaria. Eur. J. Dermatol. 11 (2001) 181-187
57. Goetzl E.J., Valacer D.J., Payan D.G., and Wong M.Y. Abnormal response to aspirin of leukocyte oxygenation of arachidonic acid in adults with aspirin intolerance. J. Allergy Clin. Immunol. 77 (1986) 693-698
58. Szczeklik A. The cyclooxygenase theory of aspirin-induced asthma. Eur. Respir. J. 3 (1990) 588-593
59. Christie T.E., Pagari P., Ford Hutchinson A.W., Charlesson S., Chee P., Arm J.P., et al. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am. Rev. Respir. Dis. 143 (1991) 1025-1029
60. Lee T.K. Mechanism of aspirin sensitivity. Am. Rev. Respir. Dis. 145 (1992) S34-S36
61. Mastalerz L., Setkowicz M., Sanak M., and Szczeklik A. Hypersensitivity to aspirin: common alterations in eicosanoid alterations in urticaria and asthma. J. Allergy Clin. Immunol. 113 (2004) 771-775
62. Mita H., Endoh S., Kudoh M., Kawagishi Y., Kobayashi M., Taniguchi M., et al. Possible involvement of mast cell activation in aspirin provocation of aspirin-induced asthma. Allergy 56 (2001) 1061-1067
63. Picado G., Ramis I., Rosello J., Prat J., Bulbena O., Plaza V., et al. Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. Am. Rev. Respir. Dis. 145 (1992) 65-69
64. Cowburn A.S., Sladek K., Soja J., Adamek L., Nizankowska E., Szczeklik A., et al. Overexpression of leukotriene C4-synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J. Clin. Invest. 101 (1998) 834-846
65. Fischer A.R., Rosenberg M.A., Lilly C.M., Callery J.C., Rubin P., Cohn J., et al. Direct evidence for a role of the mast cells in the nasal response to aspirin in aspirin-sensitive asthma. J. Allergy Clin. Immunol. 94 (1994) 1046-1056
66. Kowalski M.L., Sliwinska-Kowalska M., Igarashi Y., White M.V., Wojciechowska B., Brayton P., et al. Nasal secretions in response to acetyl-salicylic acid. J. Allergy Clin. Immunol. 91 (1993) 580-598
67. Sladek K., Dworski R., Soja J., Sheller J.R., Nizankowska E., Oates J.A., et al. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am. J. Respir. Crit. Care Med. 149 (1994) 940-946
68. Israel E., Fischer A.R., Rosenberg M.A., Lilly C.M., Callery J.C., Shapiro J., et al. The pivotal role of 5-lipooxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am. Rev. Respir. Dis. 148 (1993) 147-151
69. Pacor M.L., Di Lorenzo G., and Corrocher R. Efficacy of leukotriene receptor antagonist in chronic urticaria: a double-blind, placebo-controlled, comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid. Clin. Exp. Allergy 31 (2001) 1607-1614
70. Endres S., Whitaker R.E.D., Ghorbani R., Meydani S.M., and Dinarello C.A. Oral aspirin and ibuprofen increase cytokine-induced synthesis of IL-1β and of tumor necrosis factor-α ex vivo. Immunology 87 (1996) 264-270
71. Sousa A.R., Lams B.E.A., Pfister R., Christie P.E., Schmitz M., and Lee T.H. Expression of interleukin-5 and granulocyte colony-stimulating factor in aspirin-sensitive and non aspirin-sensitive asthmatic airways. Am. J. Respir. Crit. Care Med. 156 (1997) 1384-1389
72. Rosado A., Vives R., Gonzalez R., and Rodriguez J. Can NSAIDs intolerance disappear? A study of three cases. Allergy 58 (2003) 689-690
73. Szczeklik A. Mechanism of aspirin-induced asthma. In: Szczeklik A., Gryglewski R., and Vane J. (Eds). Eicosanoids, aspirin and asthma (1998), Marcel-Dekker, New York 299-315
74. Daxun Z., Becker W.M., Schulz K.H., and Schlaak M. Sensitivity to aspirin : a new serological diagnostic method. J. Invest. Allergol. Clin. Immunol. 3 (1993) 72-78
75. Kubota Y., Koga T., and Nakayama J. In vitro released interferon-γ in the diagnosis of drug-induced anaphylaxis. Eur. J. Dermatol. 9 (1999) 559-560
76. Fernandez-Rivas M., De La Hoz B., Cuevas M., Davila I., Quirce S., and Losada E. Hypersensitivity to anthranilic acid derivatives. Ann. Allergy 71 (1993) 515-518
77. Del Pozo M.D., Lobera T., and Blasco A. Selective hypersensitivity to diclofenac. Allergy 55 (2000) 412-413
78. Gala G., Blanco R., Quirce S., Perez-Camo I., Alvarez-Fernandez J.A., and Diez-Gomez M.L. Diclofenac-induced urticaria with aspirin tolerance. Allergy 53 (1998) 623-624
79. Prieto A., Herrero T., Rubio M., Tornero P., Baeza M.L., Velloso A., et al. A case of anaphylaxis to naproxen. Allergy 60 (2005) 660-661
80. Matheu V., Sierra Z., Gracia M.T., Caloto M., Alcazar M.M., Martinez M.I., et al. Morniflumate-induced urticaria-angioedema. Allergy 53 (1998) 812-813
81. Takahama H., Kubota Y., and Mizoguchi M. A case of anaphylaxis due to ibuprofen. J. Dermatol. 27 (2000) 337-340
82. Gamboa P.M., Sanz M.L., Caballero M.R., Antépara I., Urrutia I., Jauregui I., et al. Use of CD63 expression as a marker of in vitro basophil activation and leukotriene determination in metamizol allergic patients. Allergy 58 (2003) 312-317
83. Ellis M., Haydik A., Gillman S., Cummins L., and Cairo M.S. Immediate adverse reactions to paracetamol in children: evaluation of histamine release and spirometry. J. Pediatr. 114 (1989) 654-656
84. Grant J.A., and Weiler J.M. A report of a rare immediate reaction after ingestion of acetaminophen. Ann. Allergy Asthma Immunol. 87 (2001) 227-229
85. Leung R., Plomley R., and Czarny D. Paracetamol anaphylaxis. Clin. Exp. Allergy 22 (1992) 831-833
86. Martin J.A., Lazaro M., Cuevas M., and Alvarez Cuesta E. Hipersensibilidad al paracetamol. Med. Clin. (Barc.) 4 (1993) 44
87. Mendizabal S., and Diez-Gomez M.L. Paracetamol sensitivity without aspirin intolerance. Allergy 53 (1998) 457-458
88. Ownby D.R. Acetaminophen-induced urticaria and tolerance of ibuprofen in an eight-year-old child. J. Allergy Clin. Immunol. 99 (1997) 151-152
89. Sabbah A., Sainte-Laudy J., Drouet M., Lauret M.G., and Loiry M. Réactions anaphylactiques ou anaphylactoïdes au paracétamol : à propos de trois cas. Allergie Immunol XXIX (1997) 60-63
90. Vidal C., Perez-Carral C., and Gonzalez-Quintela A. Paracetamol (acetaminophen) hypersensitivity. Ann. Allergy Asthma Immunol. 79 (1997) 320-321
91. Vieluf D., Vieluf I., Brockow B., and Abeck D. Positive intracutaneous and oral provocation tests in a child with an anaphylactoid reaction to paracetamol. J. Allergy Clin. Immunol. 97 (1996) 356 (Abst)
92. Grob M., Pichler W.J., and Wüthrich B. Anaphylaxis to celecoxib. Allergy 57 (2002) 264-265
93. Schuster C., and Wüthrich B. Anaphylactic drug reaction to celecoxib and sulfamethoxazole: cross-reactivity or coincidence. Allergy 58 (2003) 1072
94. Cirstea M., Cirje M., and Suhaciu G. The diagnostic value of intradermal skin tests with penicilloyl-dextran and aspirin-polylysine. Physiologie 23 (1986) 237-243
95. Zhu D.X., Zhao L., Mo L., and Li H.L. Drug allergy: identification and characterization of IgE reactivities to aspirin and related compounds. J. Invest. Allergol. Clin. Immunol. 7 (1997) 160-168
96. Chandrasekharan N.V., Dai H., Roos K.L., Evanson N.K., Tomsik J., Elton T.S., et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure and expression. Proc. Natl. Acad. Sci. USA 99 (2002) 13926-13931
97. Kis B., Snipes J.A., and Busija D.W. Acetaminophen and the cyclooxygenase-3 puzzle: sorting out facts, fictions and uncertainties. J. Pharmacol. Exp. Ther. 315 (2005) 1-7
98. Nettis E., Giordano D., Colanardi M.C., Paradiso M.T., Ferrannini A., and Tursi A. Delayed-type hypersensitivity rash from ibuprofen. Allergy 58 (2003) 539-540
99. Romano A., and Pietrantonio F. Delayed hypersensitivity to flurbiprofen. J. Intern. Med. 241 (1997) 81-83
100. Ibanez M.D., Alonzo E., Munoz M.C., Martinez E., and Laso M.T. Delayed hypersensitivity reaction to paracetamol (acetaminophen). Allergy 51 (1996) 121-123
101. Mashiah J., and Brenner S. A systemic reaction to patch testing for the evaluation of acute generalized exanthematic pustulosis. Arch. Dermatol. 139 (2003) 1181-1183
102. Lebel B., Messaad D., Kvedariene K., Rougier M., Bousquet J., and Demoly P. Cysteinyl-leukotriene release test (CAST) in the diagnosis of immediate drug reactions. Allergy 56 (2001) 688-692
103. Sanz M.L., Gamboa P., and de Weck A.L. A new combined test with flowcytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs. Int. Arch. Allergy Immunol. 136 (2005) 58-72
104. Cormican L.J., Farooque S., Altmann D.R., and Lee T.H. Improvements in an oral aspirin challenge for the diagnosis of aspirin hypersensitivity. Clin. Exp. Allergy 35 (2005) 717-722
105. Kurek M., and Grubska-Suchanek E. Challenge tests with food additives and aspirin in the diagnosis of chronic urticaria. Rev. Fr. Allergol. Immunol. Clin. 41 (2001) 463-469
106. Mellilo G., Balsano G., Bianco S., Dahlén B., Godard P., Kowalsky M.L., et al. Oral and inhalation provocation tests for the diagnosis of aspirin-induced asthma (Report of the INTERASTHMA Working Group on standardization of inhalation provocation tests in aspirin-induced asthma). Allergy 56 (2001) 899-911
107. Pawlowiez A., Williams W.R., and Davies B.H. Inhalation and nasal challenge in the diagnosis of aspirin-induced asthma. Allergy 46 (1991) 405-409
108. Dahlen B., and Zetterstrom O. Comparison of bronchial and per oral provocation with aspirin in aspirin sensitive asthmatics. Eur. Respir. J. 3 (1990) 527-534
109. Widal M.F., Abrani P., and Lenmoyez J. Anaphylaxie et idiosyncrasie. Presse Med. 30 (1922) 189-192
110. Zeiss C.R., and Lockey R.F. Refractory period to aspirin in a patient with aspirin-induced asthma. J. Allergy Clin. Immunol. 57 (1976) 440-448
111. Bianco S., Robuschi M., and Petrigni C. Treatment of aspirin idiosyncrasy. J. Allergy Clin. Immunol. 70 (1982) 222
112. Sweet J.M., Stevenson D.D., Simon R.A., and Mathison D.A. Long-term effects of aspirin desensitization : treatment for aspirin-sensitive rhinosinusitis-asthma. J. Allergy Clin. Immunol. 85 (1990) 59-65
113. Szmidt M., Czelewska I., Kowalski M.L., and Rozniecki J. Tolerance of acetylsalicylic acid induced in ASA-sensitive asthmatics does not depend on initial adverse reaction. Allergy 42 (1987) 182-185
114. Baldocchi G., Vervloet D., and Charpin J. Acetylsalicylic acid therapy in aspirin-sensitive asthmatics. J. Allergy Clin. Immunol. 75 (1983) 560
115. Berges-Gimeno M.P., Simon R.A., and Stevenson D.D. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J. Allergy Clin. Immunol. 111 (2003) 180-186
116. Stevenson D.D., Pleskow W.W., Schatz M., and Keiger R.S. Aspirin-sensitive rhinosinusitis-asthma : a double-blind, cross-over study of treatment with aspirin. J. Allergy Clin. Immunol. 73 (1984) 500-507
117. Stevenson D.D., Hankammer M.A., Mathison D.A., Christiansen S.C., and Simon R.A. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J. Allergy Clin. Immunol. 98 (1996) 751-758
118. Stevenson D.D. Adverse reactions to nonsteroidal anti-inflammatory drugs. Immunol Allergy Clin. N. Amer. 18 (1998) 773-798
119. Enrique E., Garcia-Ortega P., Gaig P., and San Miguel M.M. Failure of montelukast to prevent anaphylaxis to diclofenac. Allergy 54 (1999) 529-530
120. Hamad A.M., Sutcliffe A.M., and Knox A.J. Aspirin-induced asthma: clinical aspects, pathogenesis and management. Drugs 64 (2004) 2417-2432
121. Ohnishi-Inoue Y., Mitsuya K., and Horio T. Aspirin-sensitive urticaria: provocation with a leukotriene receptor antagonist. Br. J. Dermatol. 138 (1998) 483-485
122. Cioli V., Corradino C., and Scorza Barcellona P. Review of pharmacological data on benzydamine. Int. J. Tissue React. 7 (1985) 205-213
123. Riboldi E., Frascaroli G., Transidico P., Luini W., Bernasconi S., Mancini F., et al. Benzydamine inhibits monocyte migration and MAPK activation induced by chemotactic agonists. Br. J. Pharmacol. 140 (2003) 377-383
124. Sironi M., Pozzi P., Polentarutti N., Benigni F., Coletta L., Gugielmotti A., et al. Inhibition of inflammatory cytokine production and protection against endotoxin toxicity by benzydamine. Cytokine 8 (1996) 710-716
125. Sironi M., Milanese C., Vecchi A., Polenzani L., Gugielmotti A., Coletta I., et al. Benzydamine inhibits the release of tumor necrosis factor-alpha and monocyte chemotactic protein-1 by Candida albicans-stimulated human peripheral blood cells. Int. J. Clin. Lab. Res. 27 (1997) 118-122
126. Sironi M., Massimiliano L., Transidico P., Pinza M., Sozzani S., Mantovani A., et al. Differential effect of benzydamine on pro- versus anti-inflammatory cytokine production: lack of inhibition of interleukin-10 and interleukin-1 receptor antagonist. Int. J. Clin. Lab. Res. 30 (2000) 17-19
127. Nettis E., Di Paola R., Napoli G., Ferrannini A., and Tursi A. Benzydamine: an alternative nonsteroidal anti-inflammatory drug in patients with nimesulide-induced urticaria. Allergy 57 (2002) 442-445
128. Riendeau D., Charleson S., Cromlish W., Mancini J.A., Wong E., and Guay J. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. Can. J. Physiol. Pharmacol. 75 (1997) 1088-1095
129. Gutgesell C., and Fuchs T. Azopropazone in aspirin intolerance. Allergy 54 (1999) 897-898
130. Karakaya G., and Kalyoncu A.F. Old and forgotten but cheap and safe alternatives for analgesic-intolerant patients : shall the allergists remember that they are still in the market?. Proc XXIIth Congress of the EAACI, Paris (2003) 349-350 (Abst)
131. Nizankowska E., Czemiawska-Mysic G., Bochenek G., and Szczelik A. Tolerance of azopropazone in hypersensitivity to pyrazolones and in aspirin-induced asthma. Eur. J. Allergy Clin. Immunol. S12 (1992) 22 (Abst)
132. Nizankowska E., Bochenek G., Czemiawska-Mysic G., and Szczelik A. Tolerance of pyrazolidine derivative azopropazone in hypersensitivity to pyrazolone drugs. Allergo. J. 3 (1994) 320-326